Sunshine Biopharma, Inc.

SBFM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$9,687$16,292$21,826$2,045
Short-Term Investments$0$0$0$0
Receivables$3,868$2,552$1,912$8
Inventory$11,278$5,735$3,290$106
Other Curr. Assets$1,133$311$284$37
Total Curr. Assets$25,966$24,890$27,312$2,196
Property Plant & Equip (Net)$1,482$1,013$1,155$7
Goodwill$0$0$0$0
Intangibles$3,020$1,444$777$0
Long-Term Investments$0$0$0$0
Tax Assets$92$0$301$0
Other NC Assets$0$0$0$0
Total NC Assets$4,594$2,457$2,233$7
Other Assets$0$0$0$0
Total Assets$30,560$27,347$29,545$2,203
Liabilities
Payables$5,543$2,585$2,803$43
Short-Term Debt$208$119$123$0
Tax Payable$268$300$373$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$296$2,548$3,632$48
Total Curr. Liab.$6,315$5,552$6,931$91
LT Debt$745$539$642$1,900
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$49$344$0
Other NC Liab.$0$0$0$0
Total NC Liab.$745$588$987$1,900
Other Liabilities$0$0$0$0
Cap. Leases$952$658$642$0
Total Liabilities$7,060$6,140$7,918$1,991
Equity
Pref Stock$13$1$1$100
Common Stock$3$28$23$3
Retained Earnings-$69,040-$63,906-$59,400-$32,655
AOCI-$830$696$162-$23
Other Equity$93,355$84,388$80,842$32,787
Total Equity$23,501$21,207$21,628$212
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$30,560$27,347$29,545$2,203
Net Debt-$8,734-$15,635-$21,061-$145